CYTOKINE ENHANCEMENT OF COMPLEMENT-DEPENDENT PHAGOCYTOSIS BY MACROPHAGES - SYNERGY OF TUMOR-NECROSIS-FACTOR-ALPHA AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR PHAGOCYTOSIS OF CRYPTOCOCCUS-NEOFORMANS

被引:160
作者
COLLINS, HL [1 ]
BANCROFT, GJ [1 ]
机构
[1] LONDON SCH HYG & TROP MED, DEPT CLIN SCI, KEPPEL ST, LONDON WC1E, ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1002/eji.1830220617
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have examined the regulation of complement dependent phagocytosis by macrophage-activating cytokines. Tumor necrosis factor (TNF)-alpha and granulocyte-macrophage colony-stimulating factor (GM-CSF), but not interferon-gamma, interleukin-4 or macrophage-CSF, stimulated ingestion of the encapsulated fungal pathogen Cryptococcus neoformans by resident peritoneal macrophages in vitro. This was dependent upon opsonization of the yeasts with complement, 72 h of incubation with the cytokines for maximum effect, and the obligate involvement of the macrophage CR3 receptor. TNF-alpha and GM-CSF synergized at low concentrations, resulting in dramatic up-regulation of phagocytosis when compared to either cytokine alone. Supernatants from C neoformans-specific Tcells also increased macrophage phagocytic efficiency. Finally, the administration of neutralizing mAb specific for TNF-alpha and GM-CSF increased mortality in C. neoformans-infected mice, and induced the rapid progression of disease with involvement of the brain and meninges. We conclude that TNF-alpha and GM-CSF are potent regulators of complement-dependent phagocytosis by murine macrophages. Macrophage activation with these two cytokines can completely overcome the anti-phagocytic properties of the virulent yeasts. Our results, therefore, implicate TNF-alpha and GM-CSF as important mediators of resistance to encapsulated pathogens such as C. neoformans where ingestion of the organism is a critical process in host resistance.
引用
收藏
页码:1447 / 1454
页数:8
相关论文
共 40 条
[1]  
BANCROFT GJ, 1986, J IMMUNOL, V137, P4
[2]  
BANCROFT GJ, 1989, J IMMUNOL, V143, P127
[3]  
BERGER M, 1988, BLOOD, V71, P151
[4]   STUDIES OF MACROPHAGE COMPLEMENT RECEPTOR - ALTERATION OF RECEPTOR FUNCTION UPON MACROPHAGE ACTIVATION [J].
BIANCO, C ;
GRIFFIN, FM ;
SILVERSTEIN, SC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (06) :1278-1290
[5]   THE ROLE OF EXTRACELLULAR-MATRIX PROTEINS IN THE CONTROL OF PHAGOCYTOSIS [J].
BROWN, EJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1986, 39 (05) :579-591
[6]   INFECTIONS WITH CRYPTOCOCCUS-NEOFORMANS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
CHUCK, SL ;
SANDE, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (12) :794-799
[7]  
COLEMAN DL, 1988, BLOOD, V72, P573
[8]   ENCAPSULATION OF CRYPTOCOCCUS-NEOFORMANS IMPAIRS ANTIGEN-SPECIFIC T-CELL RESPONSES [J].
COLLINS, HL ;
BANCROFT, GJ .
INFECTION AND IMMUNITY, 1991, 59 (11) :3883-3888
[9]   AGGREGATION OF COMPLEMENT RECEPTORS ON HUMAN-NEUTROPHILS IN THE ABSENCE OF LIGAND [J].
DETMERS, PA ;
WRIGHT, SD ;
OLSEN, E ;
KIMBALL, B ;
COHN, ZA .
JOURNAL OF CELL BIOLOGY, 1987, 105 (03) :1137-1145
[10]  
DIAMOND RD, 1973, P SOC EXP BIOL MED, V144, P312, DOI 10.3181/00379727-144-37580